SEARCH

SEARCH BY CITATION

References

  • 1
    Perilli M, Dell'Amico E, Segatore B et al. Molecular characterization of extended-spectrum β-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J Clin Microbiol 2002; 40: 611614.DOI: 10.1128/JCM.40.2.611-614.2002
  • 2
    Mariotte S, Nordmann P, Nicolas MH. Extended-spectrum β-lactamase in Proteus mirabilis. J Antimicrob Chemother 1994; 33: 925935.
  • 3
    Nagano N, Shibata N, Saitou Y et al. Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type β-lactamase. J Clin Microbiol 2003; 41: 55305536.DOI: 10.1128/JCM.41.12.5530-5536.2003
  • 4
    Hernandez JR, Pascual A, Canton R et al. Escherichia coli y Klebsiella pneumoniae productores de β-lactamasas de espectro extendido en hospitales espanoles (Proyecto GEIH-BLEE). Enferm Infecc Microbiol Clin 2000; 21: 7782.DOI: 10.1157/13042863
  • 5
    Rodriguez-Bano J, Navarro MD, Romero L et al. Epidemiology and clinical features of infections caused by extended-spectrum β-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004; 42: 10891094.DOI: 10.1128/JCM.42.3.1089-1094.2004
  • 6
    Colodner R, Rock W, Chazan B et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 2004; 23: 163167.
  • 7
    Borer A, Gilad J, Menashe G et al. Extended-spectrum β-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in Southern Israel. Med Sci Monit 2002, 8: CR44CR47[online].
  • 8
    Rozalski A, Sidorezyk Z, Kotelko K. Potential virulence factors of Proteus bacilli. Microbiol Mol Biol Rev 1997; 61: 6589.
  • 9
    Chanal C, Bonnet R, De Champs C et al. Prevalence of β-lactamases among 1072 clinical strains of Proteus mirabilis: a 2 year survey in a French hospital. Antimicrob Agents Chemother 2000; 44: 19301935.
  • 10
    Bonnet R, De Champs C, Sirot D et al. Diversity of TEM mutants in Proteus mirabilis. Antimicrob Agents Chemother 1999; 43: 26712677.
  • 11
    Goldstein FW, Pean Y, Rosato A et al. Characterization of ceftriaxone-resistant Enterobacteriaceae: a multicentre study in 26 French hospitals. Vigil'Roc Study Group. J Antimicrob Chemother 1993; 32: 595603.
  • 12
    Nicolas-Chanoine MH, Chardon H, Avril JL et al. Susceptibility of Enterobacteriaceae to betalactams and fluoroquinolones: a French multicentre study. Clin Microbiol Infect 1997; 3(suppl 2): 74.
  • 13
    De Champs C, Bonnet R, Sirot D et al. Clinical relevance of Proteus mirabilis in hospital patients: a two year survey. J Antimicrob Chemother 2000; 45: 537539.DOI: 10.1093/jac/45.4.537
  • 14
    Pagani L, Migliavacca R, Pallecchi L et al. Emerging extended-spectrum β-lactamase in Proteus mirabilis. J Clin Microbiol 2002; 40: 15491552.DOI: 10.1128/JCM.40.4.1549-1552.2002
  • 15
    Brun-Buisson C. Catheters et infections. Questions actuelles. Lett Infectiol 1990; V: 373378.
  • 16
    Butreau-Lemaire M, Botto H. Infection urinaire nosocomiale. In: AvrilJ-L, CarletJ, eds. Les infections nosocomiales et leur prévention. Paris: Editions Ellipses, 1998; 119131.
  • 17
    Centre de Coordination de la Lutte Contre les Infections Nosocomiales de l'Interrégion Paris-Nord. Surveillance des bactéries multirésistantes à partir du laboratoire dans les hôpitaux de l'interrégion Paris-Nord. Rapport des résultats 2001. Paris: CCLIN, 2002; 46.
  • 18
    Comité de l'Antibiogramme de la Société Française de Microbiologie. Communiqué de février 2002. Paris: CA-SFM, 2002; 23.
  • 19
    Courvalin P, Goldstein F, Philippon A et al. Détermination de la concentration minimale inhibitrice en milieu liquide, dans l'antibiogramme, 1st edn. Paris: MPC-VIDEOM, 1985; 189192.
  • 20
    Sirot J. Detection of extended-spectrum plasmid-mediated β-lactamase by disk diffusion. Clin Microbiol Infect 1996; 2(suppl 1): 3539.
  • 21
    Poyart C, Mugnier G, Quesne P et al. A novel extended-spectrum TEM-type β-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniae. Antimicrob Agents Chemother 1998; 42: 108113.
  • 22
    Biendo M, Laurans G, Thomas D et al. Regional dissemination of Salmonella enterica serovar Enteritidis is season dependent. Clin Microbiol Infect 2003; 9: 360369.
  • 23
    De Champs C, Monne C, Bonnet R et al. New TEM variant (TEM-92) produced by Proteus mirabilis and Providencia stuartii isolates. Antimicrob Agents Chemother 2001; 45: 12781280.
  • 24
    Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 22332239.
  • 25
    Regnier B. Les bactéries multirésistantes aux antibiotiques en réanimation: contexte épidémiologique et stratégies de maitrise. Pathol Biol 1996; 44: 113123.
  • 26
    Claudon A, Meunier O, Arpin C et al. Les bactéries productrices de bêtalactamases à spectre étendu: étude au Centre Hospitalo-Universitaire de Strasbourg. Med Mal Infect 2002; 32: 228240.
  • 27
    Quentin C, Arpin C, Dubois V et al. Antibiotic resistance rates and phenotypes among isolates of Enterobacteriaceae in French extra-hospital practice. Eur J Clin Microbiol Infect Dis 2004; 23: 10811085.
  • 28
    Arpin C, Dubois V, Coulange L et al. Extended-spectrum β-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob Agents Chemother 2003; 47: 35063514.
  • 29
    Bosi C, Davin-Regli C, Bornet M et al. Most Enterobacter aerogenes strains in France belong to a prevalent clone. J Clin Microbiol 1999; 37: 21652169.
  • 30
    Heseltine P. Has resistance spread to the community? Clin Microbiol Infect 2000; 6: 1116.
  • 31
    Pai H, Lyu S, Lee JH et al. Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J Clin Microbiol 1999; 37: 17581763.
  • 32
    Chanal C, Sirot D, Romaszko JP et al. Survey of prevalence of extended spectrum β-lactamases among Enterobacteriaceae. J Antimicrob Chemother 1996; 38: 127132.
  • 33
    Mammeri H, Laurans G, Eveillard M et al. Coexistence of SHV4 and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital. J Clin Microbiol 2001; 39: 21842190.